Ivabradine Oxalate is a selective If channel inhibitor utilized primarily for the management of chronic stable angina and the treatment of chronic heart failure with reduced ejection fraction in patients… Read more
Ivabradine Oxalate is a selective If channel inhibitor utilized primarily for the management of chronic stable angina and the treatment of chronic heart failure with reduced ejection fraction in patients who cannot tolerate or do not respond adequately to beta-blockers. To ensure the rigorous quality control and safety of this cardiac medication, analytical laboratories require high-quality reference materials. This category provides access to Ivabradine Oxalate reference standards, along with a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, potential metabolites, and stable isotope-labelled compounds. These research tools are essential for impurity profiling, method development, and the validation of analytical procedures in pharmaceutical manufacturing. By incorporating these precise materials into testing protocols, researchers and quality assurance teams can accurately identify and quantify related substances, ensuring compliance with regulatory standards throughout the drug development and manufacturing lifecycle.